Current Value
US$ 222,59
Market Cap
US$ 1,04 B
VARIATION (12M)
12,99%
VARIATION (60M)
62,07%
DY
1,78%
graph

CRBN PRICE

BVMF
CRBN
If you had invested
If you had invested
years ago
6 months
1 year
5 years
10 years
ago, today you would have
ago, today you would have:

Profitability of CRBN

1 month
3 months
1 year
2 years
5 years
10 years
profitability
1 month
-0,68%
3 months
4,95%
1 year
12,99%
2 years
46,51%
5 years
62,07%
10 years
139,83%

real profitability

profitability minus inflation.

1 month
-0,68%
3 months
4,56%
1 year
8,03%
2 years
33,72%
5 years
19,76%
10 years
43,59%
Cotação

COMPARISON OF CRBN WITH INDEXES

If you had invested R$ 1,000.00 (change) years ago 5 years, ago, today you would have:

*The figure considers the reinvestment of dividends.
Cotação

Dividend History iShares Trust - iShares MSCI ACWI Low Carbon Target ETF

current DY: 1,78%

5-year average DY: 2,67%

DRAG THE FRAME TO SEE MORE DATA

type

date with

payment date

value

Dividendos 16/06/2025 20/06/2025 1,70600000
Dividendos 17/12/2024 20/12/2024 2,26286000
Dividendos 11/06/2024 17/06/2024 1,49311000
Dividendos 21/12/2023 27/12/2023 1,83520000
Dividendos 08/06/2023 13/06/2023 1,49671000
Dividendos 14/12/2022 19/12/2022 1,22023000
Dividendos 10/06/2022 15/06/2022 1,46830000
Dividendos 31/12/2021 05/01/2022 0,16712000
Dividendos 14/12/2021 17/12/2021 1,40971000
Dividendos 11/06/2021 16/06/2021 1,16104000
Dividendos 15/12/2020 18/12/2020 1,06738000
Dividendos 16/06/2020 19/06/2020 1,03682000
Dividendos 17/12/2019 20/12/2019 1,52888000
Dividendos 18/06/2019 21/06/2019 1,40239000
Dividendos 19/12/2018 24/12/2018 1,28534000
Dividendos 20/06/2018 25/06/2018 1,30227000
Dividendos 20/12/2017 26/12/2017 1,24323000
Dividendos 22/06/2017 26/06/2017 1,15846000
Dividendos 23/12/2016 28/12/2016 0,94467000
Dividendos 24/06/2016 28/06/2016 1,25151000
Dividendos 23/12/2015 28/12/2015 0,93308000
Dividendos 29/06/2015 01/07/2015 0,94050000

ABOUT THE

iShares Trust - iShares MSCI ACWI Low Carbon Target ETF

Average user rating I10

4.0 (0 people)

Frequently Asked Questions

What is the price of CRBN today?

The price of CRBN today is US$ 222,59, with a variation of 12.99% compared to the last year. The price of CRBN started the year trading around US$ 193,59 and today it is at US$ 222,59. Follow the chart of real-time price, the historical price of CRBN, and all information about this ETF.

CRBN is it worth it?

Currently, CRBN is priced at US$ 222,59 and has a market capitalization of approximately US$ 1,04 Billion. In the last year, the ETF recorded a return of 12,99%, considering only the variation of the share.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy units of CRBN?

Investing in CRBN can be done in two ways: through B3, if the ETF is traded in Brazil, or through a brokerage with access to the international market, if it is a U.S. ETF.

If CRBN is listed on B3, you just need to have an account with a Brazilian brokerage, access the home broker, search by the ticker, define the quantity, and send the purchase order.

If it is an international ETF, you need to open an account with a brokerage that offers access to the U.S. market or of other exchanges. In this case, the investment will be made in dollars, and the order must be sent directly through the brokerage system.

In some cases, it is also possible to invest in the international ETF through an ETF BDR, which is traded on B3 in reais and can be accessed by any Brazilian brokerage.

How much do 100 shares of CRBN yield today?

The yield of CRBN was -0,68% in the last month and 12,99% in the last year.

If you wanted to buy 100 shares of CRBN today, the total investment would be US$ 22.259,00, based on the current price of US$ 222,59.

If past performance were to repeat, the return on your investment would be:

  • In 1 month: US$ 22.107,64
  • In 1 year: US$ 25.150,44
  • In 2 years: US$ 32.611,66

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.